Molecular approaches to the identification of unculturable infectious agents.

PubWeight™: 1.81‹?› | Rank: Top 3%

🔗 View Article (PMC 2626790)

Published in Emerg Infect Dis on December 03, 1996

Authors

S J Gao1, P S Moore

Author Affiliations

1: School of Public Health, Columbia University New York, New York 10032, USA. sg192@columbia.edu

Articles citing this

Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol (2007) 2.68

Risk assessment models and contamination management: implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology. J Clin Microbiol (2002) 2.08

Leptotrichia amnionii sp. nov., a novel bacterium isolated from the amniotic fluid of a woman after intrauterine fetal demise. J Clin Microbiol (2002) 1.76

Applications of flow cytometry to clinical microbiology. Clin Microbiol Rev (2000) 1.69

Species-independent detection of RNA virus by representational difference analysis using non-ribosomal hexanucleotides for reverse transcription. Nucleic Acids Res (2005) 1.51

PCR detection and characterization of type-2 porcine circovirus. Can J Vet Res (2000) 1.26

Presence of bacterial phage-like DNA sequences in commercial Taq DNA polymerase reagents. J Clin Microbiol (2004) 1.17

A sequence-independent in vitro transposon-based strategy for efficient cloning of genomes of large DNA viruses as bacterial artificial chromosomes. Nucleic Acids Res (2008) 0.92

Molecular techniques for clinical diagnostic virology. J Clin Pathol (2000) 0.77

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases? Emerg Infect Dis (1997) 0.75

Strategies for Human Tumor Virus Discoveries: From Microscopic Observation to Digital Transcriptome Subtraction. Front Microbiol (2016) 0.75

Current Advances on Virus Discovery and Diagnostic Role of Viral Metagenomics in Aquatic Organisms. Front Microbiol (2017) 0.75

Articles cited by this

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79

The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens. N Engl J Med (1990) 15.92

Identification of the uncultured bacillus of Whipple's disease. N Engl J Med (1992) 12.33

Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med (1996) 12.11

Searching for peptide ligands with an epitope library. Science (1990) 10.75

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet (1995) 10.63

Cloning the differences between two complex genomes. Science (1993) 10.60

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet (1990) 9.11

Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11

Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med (1995) 8.52

In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood (1995) 6.91

Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med (1995) 6.71

Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease. Lancet (1992) 6.48

Characterization of a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient. J Clin Microbiol (1992) 6.33

Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev (1996) 6.12

Rochalimaea henselae infection. A new zoonosis with the domestic cat as reservoir. JAMA (1994) 5.98

Rochalimaea henselae sp. nov., a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis. J Clin Microbiol (1992) 5.62

Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med (1992) 5.57

Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet (1992) 5.10

Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05

Isolation of novel virus-like sequences associated with human hepatitis. Nat Med (1995) 4.99

Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science (1995) 4.51

A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia. N Engl J Med (1990) 4.46

Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15

Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet (1995) 3.81

Phylogeny of the Whipple's-disease-associated bacterium. Lancet (1991) 3.57

Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31

A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med (1995) 3.30

Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A (1995) 3.30

Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74

Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis (1987) 2.68

Phylogenetic analysis of the genera Thiobacillus and Thiomicrospira by 5S rRNA sequences. J Bacteriol (1985) 2.62

Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus. Gastroenterology (1985) 2.49

Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS (1996) 2.49

Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet (1995) 2.36

Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med (1996) 2.33

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A (1995) 2.33

Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26

Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg (1994) 2.07

Outbreak of acute illness--southwestern United States, 1993. MMWR Morb Mortal Wkly Rep (1993) 1.97

Epithelioid haemangioma-like vascular proliferation in AIDS: manifestation of cat scratch disease bacillus infection? Lancet (1988) 1.92

Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci U S A (1995) 1.75

Electron microscopic study of the intestinal mucosa in Whipple's disease. Demonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology (1961) 1.74

The new GB hepatitis viruses. Lancet (1995) 1.71

Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood (1989) 1.69

Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol (1995) 1.67

An atypical subcutaneous infection associated with acquired immune deficiency syndrome. Am J Clin Pathol (1983) 1.59

Evidence for a sexually transmitted cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men. Epidemiology (1992) 1.53

The cloning and clinical implications of HGV and HGBV-C. N Engl J Med (1996) 1.50

Epidemiologic clues to the etiology of Kaposi's sarcoma. AIDS (1993) 1.47

Epithelioid angiomatosis in HIV infection: neoplasm or cat-scratch disease? Lancet (1988) 1.31

HHV8 and skin cancers in immunosuppressed patients. Lancet (1996) 1.29

Unraveling mysteries associated with cat-scratch disease, bacillary angiomatosis, and related syndromes. Emerg Infect Dis (1996) 1.27

The identification of uncultured microbial pathogens. J Infect Dis (1993) 1.27

Geography in multiple sclerosis. J Neurol (1977) 1.26

Kaposi's sarcoma and new herpesvirus. Lancet (1995) 1.24

Epidemiology of Hantaan and related viruses. Lab Anim Sci (1987) 1.17

Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis (1994) 1.15

Mycobacterial aetiology of sarcoidosis. Lancet (1992) 1.14

Retracted Is Kaposi's-sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men? Lancet (1995) 1.11

New viral footprints in Kaposi's sarcoma. N Engl J Med (1995) 1.11

Multiple sclerosis and viruses: an overview. Neurology (1980) 1.10

On the fine structure of the distribution of multiple sclerosis. Acta Neurol Scand (1967) 1.07

Studies of GB hepatitis agent in tamarins. Hepatology (1989) 1.00

Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res (1994) 0.99

Is risk of Kaposi's sarcoma in AIDS patients in Britain increased if sexual partners came from United States or Africa? BMJ (1991) 0.97

Update: outbreak of hantavirus infection--southwestern United States, 1993. MMWR Morb Mortal Wkly Rep (1993) 0.96

A new human herpesvirus: KSHV or HHV8? Lancet (1995) 0.91

The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery. AIDS (1996) 0.90

Transmission of human non-A, non-B hepatitis to chimpanzees following failure to transmit GB agent hepatitis. J Med Virol (1980) 0.89

Herpesvirus saimiri-induced lymphoproliferative disease in howler monkeys. J Natl Cancer Inst (1977) 0.85

Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet (1996) 0.84

Epstein-Barr virus--associated lymphoproliferative lesions. Clin Lab Med (1988) 0.84

Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS Study. J Acquir Immune Defic Syndr (1990) 0.83

Transmission of viral hepatitis to nonhuman primates. Vox Sang (1971) 0.79

Some epidemiologic features compatible with an infectious origin for multiple sclerosis. Int Arch Allergy Appl Immunol (1969) 0.78

Articles by these authors

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89

In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood (1995) 6.91

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96

Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol (1998) 4.62

The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol (1997) 4.56

Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70

Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol (1996) 3.48

Cyclin encoded by KS herpesvirus. Nature (1996) 3.32

The care of elderly patients with hip fracture. Changes since implementation of the prospective payment system. N Engl J Med (1988) 2.67

Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood (1999) 2.65

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene (1997) 2.57

Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol (2000) 2.55

Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol (1999) 2.41

Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med (1996) 2.33

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol (2001) 2.21

Global epidemiology of meningococcal disease. Clin Microbiol Rev (1989) 2.11

A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem (1997) 2.00

Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95

Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis (1996) 1.88

Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood (1999) 1.84

Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol (1997) 1.72

Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia (1996) 1.63

Human herpesvirus 8 variants. Lancet (1998) 1.59

A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. J Infect Dis (1992) 1.56

Retracted Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc Natl Acad Sci U S A (1999) 1.52

Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol (1999) 1.49

Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how? Trends Microbiol (1999) 1.49

Risk factors for adverse outcome in persons with pneumococcal pneumonia. Chest (1995) 1.44

Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS (1998) 1.40

First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations. Am J Trop Med Hyg (1998) 1.35

Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology. Adv Virus Res (1999) 1.35

KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol (1999) 1.30

High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res (2001) 1.20

National surveillance of Lyme disease, 1987-1988. Conn Med (1989) 1.13

Patterns of referral and examination for retinopathy in pregnant women with diabetes by primary care physicians. Ophthalmic Epidemiol (1995) 1.13

Epidemiologic aspects of a St. Louis encephalitis epidemic in Jefferson County Arkansas, 1991. Am J Trop Med Hyg (1993) 1.12

Allelotype of pancreatic acinar cell carcinoma. Int J Cancer (2000) 1.11

Outbreak of Japanese encephalitis on the island of Saipan, 1990. J Infect Dis (1993) 1.08

Postdischarge care and readmissions. Med Care (1988) 1.08

Successful xenografting of cryopreserved primary pancreatic cancers. Virchows Arch (2001) 1.07

Antagonism between high pressure and anesthetics in the thermal phase-transition of dipalmitoyl phosphatidylcholine bilayer. Biochim Biophys Acta (1979) 1.07

Atypical measles following immunization with killed measles vaccine. Can Med Assoc J (1970) 1.05

Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood (1997) 1.04

The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). N Engl J Med (2000) 1.01

Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol (2003) 1.01

Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping. Int J Cancer (2001) 0.94

Mechanism-based inactivation of dopa decarboxylase by serotonin. J Biol Chem (1996) 0.94

Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol (2002) 0.93

Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label. Biochemistry (1998) 0.92

Dissociation, unfolding and refolding trials of pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. Biochem J (1993) 0.92

The cost-effectiveness of intensive postdischarge care. A randomized trial. Med Care (1988) 0.91

Merkel cell polyomavirus and non-small cell lung cancer. Br J Cancer (2013) 0.91

The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery. AIDS (1996) 0.90

Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay. J Infect Dis (2000) 0.89

Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation. Protein Sci (1997) 0.87

Constituents of Eriobotrya japonica. A study of their antiviral properties. J Nat Prod (1992) 0.85

Human immunodeficiency virus (HIV) seroprevalence in persons attending STD clinics in the United States, 1985-1987. Sex Transm Dis (1990) 0.85

Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc. Br J Haematol (1999) 0.84

Kaposi's sarcoma-associated herpesvirus: a sexually transmissible infection? J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.83

Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding. J Mol Biol (2001) 0.83

Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage. Transplant Proc (2008) 0.82

Kaposi's sarcoma findings. Science (1995) 0.82

Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel. Anticancer Res (2000) 0.82

Alteration of chromosome arm 6p is characteristic of primary mediastinal B-cell lymphoma, as identified by genome-wide allelotyping. Genes Chromosomes Cancer (2001) 0.81

Infectious disease surveillance during emergency relief to Bhutanese refugees in Nepal. JAMA (1994) 0.80

Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Ann Intern Med (1996) 0.79

Genetic alterations in primary mediastinal B-cell lymphoma: an update. Leuk Lymphoma (2001) 0.79

Identification of a novel polymorphism in the fibronectin type II domain of the SEL1L gene and possible relation to the persistent hyperinsulinemic hypoglycemia of infancy. Mutat Res (2004) 0.78

Modified purification of L-aromatic amino acid decarboxylase from pig kidney. Protein Expr Purif (1993) 0.78

Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer. Br J Surg (2001) 0.78

The treatment of patients with insulin-requiring diabetes mellitus by primary care physicians. J Community Health (1991) 0.77

Mail-in paper strip vs. microcolumn technique for measurement of glycosylated hemoglobin. Diabetes Care (1990) 0.77

Nonrandom chromosomal imbalances in primary mediastinal B-cell lymphoma detected by arbitrarily primed PCR fingerprinting. Genes Chromosomes Cancer (1999) 0.77

Preliminary X-ray analysis of a new crystal form of recombinant pig kidney DOPA decarboxylase. Acta Crystallogr D Biol Crystallogr (1999) 0.76

Nursing deans in small, liberal arts colleges and universities: roles, challenges, and opportunities. J Prof Nurs (1987) 0.75

New directions in molecular techniques for pathogen identification. Trends Microbiol (1998) 0.75

Retraction. Proc Natl Acad Sci U S A (2001) 0.75

Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. What is the current evidence for causality? Arch Dermatol (1997) 0.75

Communicating nursing research: another look at the use of poster sessions in undergraduate programs. Nurse Educ (1989) 0.75

[The anatomical pathologist and the diagnosis of genetic risk]. Pathologica (2000) 0.75

Acute sensory neuropathy associated with rabbit antithymocyte globulin. Am J Transplant (2007) 0.75

Merkel cell polyomavirus small T antigen induces genome instability by E3 ubiquitin ligase targeting. Oncogene (2017) 0.75

Kaposi's sarcoma--associated herpesvirus: a newly recognized pathogen. AIDS Clin Rev (1997) 0.75

Detection of bladder cancer by semi-automated microsatellite analysis of urine sediment. Adv Clin Path (2000) 0.75

Meeting patients' spiritual needs: the Jewish perspective. Holist Nurs Pract (1992) 0.75

DNA array/microarrays in oncological research with focus on pancreatic cancer. Adv Clin Path (2001) 0.75

Commission on Nursing Research successfully launches MAREDAC - a network for nursing research. Mass Nurse (1983) 0.75

Predicting post-hospital discharge health care costs. J Ambul Care Manage (1992) 0.75

Response. Science (1995) 0.75

Pituitary-gonadal axis in prepubertal boys with the fragile X syndrome. Am J Med Genet (1991) 0.75

Corrected prevalence of Kaposi's sarcoma (KS)-associated herpesvirus infection prior to onset of KS. AIDS (1997) 0.75